AI & Digital Health Webinar

Kiran Dattani
Customer Success
Transformation, Strategy & Architecture 
Google Cloud

Mr. Dattani is a seasoned AI Specialist & Technologist with over 20 years of experience in the life sciences and pharmaceutical industries. He has a proven track record of driving AI & digital transformation, automation and data science initiatives for leading organizations like Pfizer and Google. Mr. Dattani’s expertise spans AI healthcare practice, enterprise architecture, cloud enablement, AI and data solution delivery. He has a passion for leveraging technology to improve Patient outcomes.

Seemi Kazmi
Executive Director
Product Management, Digital Health
Bristol Myers Squibb

Ms. Kazmi is Executive Director and Digital Health TA Lead for Cardiovascular and Neuroscience. She is responsible for defining digital health strategy and implementing innovative solutions across the pharma value chain, both in commercial and clinical development. Ms. Kazmi is responsible for the global roadmap of a portfolio of solutions that includes first-in-class AI-based algorithms for Patient identification and clinical decision support, biometric sensors/wearables for remote Patient monitoring, tools integrated into EMRs and novel digital biomarkers of disease.

Scott Ogden
Head, AI Labs
Genmab

Mr. Ogden heads up the AI Innovation Lab at Genmab, where he’s focused on bringing leading, novel solutions to the forefront of biotech. With a background in computation, Mr. Ogden has spent his working years building healthcare innovation teams across the different sectors, including payors and providers. He’s currently juggling his role at Genmab with working on his EMBA at Wharton, studying entrepreneurship. During the program, he will share some down-to-earth insights on how Genmab is using AI to push the envelope on the end-to-end drug development lifecycle.

Troy Sarich, Ph.D.
Chief Commercial Data Science Officer
Johnson & Johnson Innovative Medicine

Dr. Sarich leads teams that leverage the power of artificial intelligence and machine learning, real-world evidence (RWE), digital health and precision medicine across J&J’s global regions and multiple therapeutic areas. During his nearly 20-year tenure at J&J, Dr. Sarich has delivered business transformation and Patient impact across the Innovative Medicine sector’s R&D and Commercial teams, including as Vice President, RWE, Global Head of R&D Strategy, founding co-chair and member of the J&J AI Council and in pivotal roles in the clinical development of INVOKANA® and XARELTO®.